Bonadio, R.R. da C.C. et al. 2026. Dose-dense versus 3-weekly ac during neoadjuvant chemoimmunotherapy for early-stage triple-negative breast cancer: GBECAM 0123 – the neo-real study. Mastology. 34, suppl. 1 (Mar. 2026). DOI:https://doi.org/10.29289/259453942024V34S1014.